Atas, N. Et Al. 2022. The impact of anti-TNF treatment on Wnt signaling, noggin, and cytokine levels in axial spondyloarthritis. Clinical Rheumatology , vol.41, no.5 , 1381-1389.

Atas, N., Çakır, B., BAKIR, F., UÇAR, M., Satış, H., Güz, G. T., ... Demirel, K. D.(2022). The impact of anti-TNF treatment on Wnt signaling, noggin, and cytokine levels in axial spondyloarthritis. Clinical Rheumatology , vol.41, no.5, 1381-1389.

Atas, Nuh Et Al. "The impact of anti-TNF treatment on Wnt signaling, noggin, and cytokine levels in axial spondyloarthritis," Clinical Rheumatology , vol.41, no.5, 1381-1389, 2022

Atas, Nuh Et Al. "The impact of anti-TNF treatment on Wnt signaling, noggin, and cytokine levels in axial spondyloarthritis." Clinical Rheumatology , vol.41, no.5, pp.1381-1389, 2022

Atas, N. Et Al. (2022) . "The impact of anti-TNF treatment on Wnt signaling, noggin, and cytokine levels in axial spondyloarthritis." Clinical Rheumatology , vol.41, no.5, pp.1381-1389.

@article{article, author={Nuh Atas Et Al. }, title={The impact of anti-TNF treatment on Wnt signaling, noggin, and cytokine levels in axial spondyloarthritis}, journal={Clinical Rheumatology}, year=2022, pages={1381-1389} }